22.01 USD
▲+1.99+9.94%
盘后 21.99 -0.09%
2026-09-04
市值
$674.47M
市盈率
—
EPS
-28.59
股息率
—
52 周区间
15.25 – 22.16
成交量
168.70K
Beta
—
目标价
31.00
52W 低 15.2552W 高 22.16
价格走势
公司简介
BlossomHill Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops small molecule medicines that address medical needs in cancer treatment. Its pipeline includes BH-30643, an OMNI-EGFR inhibitor in clinical development for advanced EGFR-mutant non-small cell lung cancer (NSCLC), BH-501284, and BH-30236, a macrocyclic CLK (Cdc2-like kinase) inhibitor being evaluated in patients with relapsed or refractory acute myeloid leukemia (R/R AML) and higher-risk myelodysplastic syndrome (HR-MDS). BlossomHill Therapeutics, Inc. was incor...